Indraprastha Medical
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
May 12 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER PAT 417 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER REVENUE FROM OPERATIONS 3.65 BILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION LTD - DIVIDEND OF 4 RUPEES PER SHARE
Source text: [ID:]
Further company coverage: IMCL.NS
(([email protected];))
May 12 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER PAT 417 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER REVENUE FROM OPERATIONS 3.65 BILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION LTD - DIVIDEND OF 4 RUPEES PER SHARE
Source text: [ID:]
Further company coverage: IMCL.NS
(([email protected];))
Feb 3 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
DEC-QUARTER PAT 410 MILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 3.72 BILLION RUPEES
Further company coverage: IMCL.NS
(([email protected];))
Feb 3 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
DEC-QUARTER PAT 410 MILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 3.72 BILLION RUPEES
Further company coverage: IMCL.NS
(([email protected];))
Nov 1 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
DISCLOSURE REGARDING MEDIA ALLEGATIONS CONCERNING AN ASSOCIATE DOCTOR
ALLEGED IRREGULARITIES ON KIDNEY TRANSPLANT PRACTICES NOT AT OUR HOSPITAL
Source text: ID:nBSE2wrzBS
Further company coverage: IMCL.NS
(([email protected];;))
Nov 1 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
DISCLOSURE REGARDING MEDIA ALLEGATIONS CONCERNING AN ASSOCIATE DOCTOR
ALLEGED IRREGULARITIES ON KIDNEY TRANSPLANT PRACTICES NOT AT OUR HOSPITAL
Source text: ID:nBSE2wrzBS
Further company coverage: IMCL.NS
(([email protected];;))
Oct 30 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
SEPT-QUARTER PAT 424 MILLION RUPEES
SEPT-QUARTER REVENUE FROM OPERATIONS 3.5 BILLION RUPEES
Source text: ID:nBSEvh0lx
Further company coverage: IMCL.NS
(([email protected];;))
Oct 30 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
SEPT-QUARTER PAT 424 MILLION RUPEES
SEPT-QUARTER REVENUE FROM OPERATIONS 3.5 BILLION RUPEES
Source text: ID:nBSEvh0lx
Further company coverage: IMCL.NS
(([email protected];;))
** Shares of Indraprastha Medical Corp IMCL.NS jump as much as 20% to hit a record high of 262.80 rupees
** Co on Monday reported ~47% jump in Q1 profit, while rev rose 13.5% y/y
** IMCL stock is top gainer among hospital-related shares, up 75% YTD
** Shares of peers Max Healthcare MAXE.NS up 26%, Rainbow Children's RAIB.NS up 1%, Fortis Healthcare FOHE.NS up 23%, Narayana Hrudayalaya NARY.NS up 4%, while Apollo Hospital APLH.NS up 17% YTD
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
** Shares of Indraprastha Medical Corp IMCL.NS jump as much as 20% to hit a record high of 262.80 rupees
** Co on Monday reported ~47% jump in Q1 profit, while rev rose 13.5% y/y
** IMCL stock is top gainer among hospital-related shares, up 75% YTD
** Shares of peers Max Healthcare MAXE.NS up 26%, Rainbow Children's RAIB.NS up 1%, Fortis Healthcare FOHE.NS up 23%, Narayana Hrudayalaya NARY.NS up 4%, while Apollo Hospital APLH.NS up 17% YTD
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
** Shares of hospital chain Aster DM Healthcare ATRD.NS rise 5.3% to 365 rupees
** Co on Wednesday reported 81% surge in Q1 profit, on higher bed occupancy rates
** ATRD up 17% YTD; Fortis Healthcare FOHE.NS rises 20%, Indraprastha Medical Corp IMCL.NS surges 55%, Max Healthcare MAXE.NS climbs 34%, Apollo Hospitals APLH.NS rises 16%
** ATRD, FOHE, MAXE & APLH "buy" rated on avg; IMCL not rated - LSEG
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
** Shares of hospital chain Aster DM Healthcare ATRD.NS rise 5.3% to 365 rupees
** Co on Wednesday reported 81% surge in Q1 profit, on higher bed occupancy rates
** ATRD up 17% YTD; Fortis Healthcare FOHE.NS rises 20%, Indraprastha Medical Corp IMCL.NS surges 55%, Max Healthcare MAXE.NS climbs 34%, Apollo Hospitals APLH.NS rises 16%
** ATRD, FOHE, MAXE & APLH "buy" rated on avg; IMCL not rated - LSEG
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
May 17 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDRAPRASTHA MEDICAL CORPORATION LTD - DIVIDEND 4.5 RUPEESPER SHARE
INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER PAT 311.7 MILLION RUPEES VERSUS 198.4 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER REVENUE FROM OPERATIONS 3.15 BILLION RUPEES VERSUS 2.74 BILLION RUPEES
Source text for Eikon: ID:nBSE83P0Vk
Further company coverage: IMCL.NS
(([email protected];))
May 17 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDRAPRASTHA MEDICAL CORPORATION LTD - DIVIDEND 4.5 RUPEESPER SHARE
INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER PAT 311.7 MILLION RUPEES VERSUS 198.4 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION LTD MARCH-QUARTER REVENUE FROM OPERATIONS 3.15 BILLION RUPEES VERSUS 2.74 BILLION RUPEES
Source text for Eikon: ID:nBSE83P0Vk
Further company coverage: IMCL.NS
(([email protected];))
** Shares of healthcare firm Indraprastha Medical Corp IMCL.NS rise as much as ~20% to hit record high, last up 17%
** Stock up 42% for the week - biggest weekly gain in at least 10 yrs, per available LSEG data
** Reuters could not immediately ascertain the reason for stock move
** Stock on track to log steepest intraday gains since June 9, 2021
** Sees busiest trading day since May 5, 2021; volumes at 17.5x 30-day avg
** Including session's gains, stock up 41% YTD
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shares of healthcare firm Indraprastha Medical Corp IMCL.NS rise as much as ~20% to hit record high, last up 17%
** Stock up 42% for the week - biggest weekly gain in at least 10 yrs, per available LSEG data
** Reuters could not immediately ascertain the reason for stock move
** Stock on track to log steepest intraday gains since June 9, 2021
** Sees busiest trading day since May 5, 2021; volumes at 17.5x 30-day avg
** Including session's gains, stock up 41% YTD
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
Feb 6 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDRAPRASTHA MEDICAL CORPORATION DEC-QUARTER PAT 294.4 MILLION RUPEES VERSUS PROFIT 209 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION DEC-QUARTER REVENUE FROM OPERATIONS 3.06 BILLION RUPEES VERSUS 2.77 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: IMCL.NS
(([email protected];))
Feb 6 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDRAPRASTHA MEDICAL CORPORATION DEC-QUARTER PAT 294.4 MILLION RUPEES VERSUS PROFIT 209 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION DEC-QUARTER REVENUE FROM OPERATIONS 3.06 BILLION RUPEES VERSUS 2.77 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: IMCL.NS
(([email protected];))
Corrects 3rd bullet to clarify that the Telegraph report said Apollo was embroiled in a "cash for kidneys" racket; removes reference to Apollo Hospitals Group enticing young villagers from Myanmar to sell their kidneys to rich patients around the world
** Shares of Indraprastha Medical Corporation IMCL.NS extend losses from the previous session to trade down as much as 5% at 189.95 rupees
** IMCL, which manages two Apollo APLH.NS hospitals in Delhi, denied allegations of its involvement in illegal kidney transplants
** UK's Telegraph newspaper reported on Saturday that Apollo was embroiled in a "cash for kidneys" racket in which impoverished people from Myanmar were being enticed to sell their organs for profit
** IMCL says has initiated inquiry into all aspects of the transplant process
** More than 245,000 shares change hands, 1.7x their 30-day avg
** APLH last down 0.3%; IMCL shares have more than doubled YTD, while APLH has risen 24%
(Reporting by Rama Venkat in Bengaluru)
Corrects 3rd bullet to clarify that the Telegraph report said Apollo was embroiled in a "cash for kidneys" racket; removes reference to Apollo Hospitals Group enticing young villagers from Myanmar to sell their kidneys to rich patients around the world
** Shares of Indraprastha Medical Corporation IMCL.NS extend losses from the previous session to trade down as much as 5% at 189.95 rupees
** IMCL, which manages two Apollo APLH.NS hospitals in Delhi, denied allegations of its involvement in illegal kidney transplants
** UK's Telegraph newspaper reported on Saturday that Apollo was embroiled in a "cash for kidneys" racket in which impoverished people from Myanmar were being enticed to sell their organs for profit
** IMCL says has initiated inquiry into all aspects of the transplant process
** More than 245,000 shares change hands, 1.7x their 30-day avg
** APLH last down 0.3%; IMCL shares have more than doubled YTD, while APLH has risen 24%
(Reporting by Rama Venkat in Bengaluru)
Dec 5 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
VEHEMENTLY DENIES SUGGESTION OF WILLFUL COMPLICITY OR IMPLICIT SANCTIONING OF ILLEGAL ACTIVITIES RELATING TO ORGAN TRANSPLANTS
IMCL INITIATED INQUIRY INTO MATTER TO DELVE INTO ALL ASPECTS OF TRANSPLANT PROCESS
IMCL DOES NOT SEEK UNRELATED DONORS NOR ITS REPRESENTATIVES ARE AUTHORIZED TO FIND UNRELATED DONORS FOR KIDNEY PATIENTS
Source text for Eikon: ID:nBSE6x4Cyk
Further company coverage: IMCL.NS
(([email protected];))
Dec 5 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
VEHEMENTLY DENIES SUGGESTION OF WILLFUL COMPLICITY OR IMPLICIT SANCTIONING OF ILLEGAL ACTIVITIES RELATING TO ORGAN TRANSPLANTS
IMCL INITIATED INQUIRY INTO MATTER TO DELVE INTO ALL ASPECTS OF TRANSPLANT PROCESS
IMCL DOES NOT SEEK UNRELATED DONORS NOR ITS REPRESENTATIVES ARE AUTHORIZED TO FIND UNRELATED DONORS FOR KIDNEY PATIENTS
Source text for Eikon: ID:nBSE6x4Cyk
Further company coverage: IMCL.NS
(([email protected];))
Nov 3 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDRAPRASTHA MEDICAL CORPORATION LTD SEPT-QUARTER PAT 328.5 MILLION RUPEES VERSUS 251.3 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION LTD SEPT-QUARTER REVENUE FROM OPERATIONS 3.17 BILLION RUPEES VERSUS 2.84 BILLION RUPEES
Source text for Eikon: ID:nBSE6zZvpH
Further company coverage: IMCL.NS
(([email protected];))
Nov 3 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDRAPRASTHA MEDICAL CORPORATION LTD SEPT-QUARTER PAT 328.5 MILLION RUPEES VERSUS 251.3 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION LTD SEPT-QUARTER REVENUE FROM OPERATIONS 3.17 BILLION RUPEES VERSUS 2.84 BILLION RUPEES
Source text for Eikon: ID:nBSE6zZvpH
Further company coverage: IMCL.NS
(([email protected];))
Aug 4 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDIA'S INDRAPRASTHA MEDICAL CORPORATION JUNE-QUARTER PAT 305 MILLION RUPEES VERSUS PROFIT 202.8 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION JUNE-QUARTER REVENUE FROM OPERATIONS 3.07 BILLION RUPEES VERSUS 2.63 BILLION RUPEES
Source text for Eikon: ID:nNSE2t0MZR
Further company coverage: IMCL.NS
(([email protected];;))
Aug 4 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
INDIA'S INDRAPRASTHA MEDICAL CORPORATION JUNE-QUARTER PAT 305 MILLION RUPEES VERSUS PROFIT 202.8 MILLION RUPEES
INDRAPRASTHA MEDICAL CORPORATION JUNE-QUARTER REVENUE FROM OPERATIONS 3.07 BILLION RUPEES VERSUS 2.63 BILLION RUPEES
Source text for Eikon: ID:nNSE2t0MZR
Further company coverage: IMCL.NS
(([email protected];;))
May 23 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
MARCH-QUARTER PAT 198.4 MILLION RUPEES VERSUS 152 MILLION RUPEES
MARCH-QUARTER REVENUE FROM OPERATIONS 2.74 BILLION RUPEES VERSUS 2.16 BILLION RUPEES
DIVIDEND 3 RUPEES PER SHARE
Source text for Eikon: ID:nBSEc2y8nY
Further company coverage: IMCL.NS
(([email protected];))
May 23 (Reuters) - Indraprastha Medical Corporation Ltd IMCL.NS:
MARCH-QUARTER PAT 198.4 MILLION RUPEES VERSUS 152 MILLION RUPEES
MARCH-QUARTER REVENUE FROM OPERATIONS 2.74 BILLION RUPEES VERSUS 2.16 BILLION RUPEES
DIVIDEND 3 RUPEES PER SHARE
Source text for Eikon: ID:nBSEc2y8nY
Further company coverage: IMCL.NS
(([email protected];))
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Indraprastha Medical do?
Indraprastha Medical Corporation Ltd provides a wide range of medical services and is expanding to set up satellite clinics for post-treatment care.
Who are the competitors of Indraprastha Medical?
Indraprastha Medical major competitors are Artemis MedicareServ, Dr Agarwals Eye Hosp, KMC Speciality Hosp., Shalby, Kovai Medical Center, Aashka Hospitals, Fortis MalarHospital. Market Cap of Indraprastha Medical is ₹3,454 Crs. While the median market cap of its peers are ₹2,148 Crs.
Is Indraprastha Medical financially stable compared to its competitors?
Indraprastha Medical seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Indraprastha Medical pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Indraprastha Medical latest dividend payout ratio is 25.62% and 3yr average dividend payout ratio is 30.27%
How has Indraprastha Medical allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Indraprastha Medical balance sheet?
Balance sheet of Indraprastha Medical is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Indraprastha Medical improving?
Yes, profit is increasing. The profit of Indraprastha Medical is ₹184 Crs for TTM, ₹161 Crs for Mar 2025 and ₹124 Crs for Mar 2024.
Is the debt of Indraprastha Medical increasing or decreasing?
Yes, The net debt of Indraprastha Medical is increasing. Latest net debt of Indraprastha Medical is -₹263.3 Crs as of Mar-26. This is greater than Mar-25 when it was -₹642.69 Crs.
Is Indraprastha Medical stock expensive?
Yes, Indraprastha Medical is expensive. Latest PE of Indraprastha Medical is 18.81, while 3 year average PE is 17.79. Also latest EV/EBITDA of Indraprastha Medical is 11.95 while 3yr average is 9.97.
Has the share price of Indraprastha Medical grown faster than its competition?
Indraprastha Medical has given better returns compared to its competitors. Indraprastha Medical has grown at ~57.55% over the last 4yrs while peers have grown at a median rate of 20.35%
Is the promoter bullish about Indraprastha Medical?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Indraprastha Medical is 51.0% and last quarter promoter holding is 51.0%.
Are mutual funds buying/selling Indraprastha Medical?
The mutual fund holding of Indraprastha Medical is stable. The current mutual fund holding in Indraprastha Medical is 0.01% while previous quarter holding is 0.01%.